课题基金 / 基金详情

BIOLOGICAL EFFECT AND CLINICAL EFFICACY OF OCTREOTIDE, ANALOG OF SOMATOSTATIN

BIOLOGICAL EFFECT AND CLINICAL EFFICACY OF OCTREOTIDE, ANALOG OF SOMATOSTATIN
生长抑素类似物奥曲肽的生物学效应和临床疗效
批准号：
6279911
负责人：
ALAN C MOSES
金额：
$2.49万
依托单位：
BETH ISRAEL DEACONESS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6279911
关键词：
acromegaly clinical research drug screening /evaluation endocrine disorder endocrine disorder chemotherapy hormone therapy human subject human therapy evaluation octreotide pharmacokinetics

项目摘要

项目成果

ALAN C MOSES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This protocol will investigate the pharmacodynamics and biological efficacy of a potent analog of somatostatin, octreotide, that has a prolonged half-life in man. Octreotide will be examined in patients with acromegaly and a variety of rare endocrine hypersecretion states.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INSULIN AND INSULINLIKE GROWTH FACTOR RESPONSES
CHARACTERIZATION OF INSULIN & INSULIN LIKE GROWTH FACTOR RESPONSES
INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM
TROGLITAZONE IN MODERATE TO SEVERE INSULIN RESISTANCE
海外基金